Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

Diabetes

Volumn 49, Issue 2, 2000, Pages 263-271

  Nikoulina, Svetlana E ^b   Ciaraldi, Theodore P ^b   Mudaliar, Sunder ^b   Mohideen, Pharis ^b   Carter, Leslie ^b   Henry, Robert R ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GLYCOGEN SYNTHESIS; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

EID: 0033958644     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.2.263     Document Type: Article

References (54)

1. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy [see comments]. N Engl J Med 322:223-228, 1990
2. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
3. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR: Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85:522-529, 1990
4. Beck-Nielsen H, Vaag A, Damsbo P, Handberg A, Nielsen OH, Henriksen JE, Thye-Ronn P: Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15:418-429, 1992
5. Bogardus C, Lillioja S, Stone K, Mott D: Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73:1185-1190, 1984
6. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O: Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 91:2342-2350, 1993
7. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O: Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40:1740-1745, 1991
8. Lawrence JC Jr, Roach PJ: New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46:541-547, 1997
9. Roach PJ: Control of glycogen synthase by hierarchal protein phosphorylation. FASEB J 4:2961-2968, 1990
10. Skurat AV, Roach PJ: Multiple mechanisms for the phosphorylation of C-terminal regulatory sites in rabbit muscle glycogen synthase expressed in COS cells. Biochem J 313:45-50, 1996
11. Zhang W, DePaoli-Roach AA, Roach PJ: Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase. Arch Biochem Biophys 304:219-225, 1993
12. Eldar-Finkelman H, Argast GM, Foord O, Fischer EH, Krebs EG: Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc Nat Acad Sci U S A 93:10228-10233, 1996
13. Hubbard MJ, Cohen P: On target with a new mechanism for the regulation of protein phosphorylation. Trends Biochem Sci 18:172-177, 1993
14. Parker PJ, Caudwell FB, Cohen P: Glycogen synthase from rabbit skeletal muscle: effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur J Biochem 130:227-234, 1983
15. Barriocanal LA, Borthwick AC, Stewart M, Wells A, Hurel SJ, Yeaman SJ, Taylor R: The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects. Diabet Med 12:1110-1115, 1995
16. Cross DA, Watt PW, Shaw M, van der Kaay J, Downes CP, Holder JC, Cohen P: Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett 406:211-215, 1997
17. Shaw M, Cohen P, Alessi DR: Further evidence that the inhibition of glycogen synthase kinase-3bela by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett 416:307-311, 1997
18. Welsh GI, Proud CG: Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294:625-629, 1993
19. Murai H, Okazaki M, Kikuchi A: Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett 392:153-160, 1996
20. Moule SK, Welsh GI, Edgell NJ, Foulstone EJ, Proud CG, Denton RM: Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells: activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J Biol Chem 272:7713-7719, 1997
21. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789, 1995
22. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736, 1995
23. Hurel SJ, Rochford JJ, Borthwick AC, Wells AM, Vandenheede JR, Turnbull DM, Yeaman SJ: Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J 320:871-877, 1996
24. Woodgett JR: Molecular cloning and expression of glycogen synthase kinase-3/ factor A. Embo J 9:2431-2438, 1990
25. Woodgett JR: Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin Cancer Biol 5:269-275, 1994
26. Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ: Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem 269:14566-14574, 1994
27. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR: Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. Embo J 12: 803-808, 1993
28. Yu JS, Chen HC, Yang SD: Reversible tyrosine phosphorylation/dephosphorylation of proline-directed protein kinase FA/glycogen synthase kinase-3alpha in A431 cells. J Cell Physiol 171:95-103, 1997
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
30. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR: Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87:489-495, 1991
31. Burnette WN: "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195-203, 1981
32. Henry RR, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Nikoulina SE: Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects: biochemical and molecular mechanisms. J Clin Invest 98:1231-1236, 1996
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
34. Orho M, Nikula-Ijas P, Schalin-Jantti C, Permutt MA, Groop LC: Isolated and characterization of the human muscle glycogen synthase gene. Diabetes 44:1099-1105, 1995
35. Shimokawa K, Kadowaki H, Sakura H, Otabe S, Hagura R, Kosaka K, Yazaki Y, Akanuma YT, Kadowaki T: Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 202:463-469, 1994
36. Shimomura H, Sanke T, Ueda K, Hanabusa T, Sakagashira S, Nanjo K: A missense mutation of the muscle glycogen synthase gene (M416V) is associated with insulin resistance in the Japanese population. Diabetologia 40:947-952, 1997
37. Zhang Y, Wat N, Stratton IM, Warren-Perry MG, Orho M, Groop L, Turner RC: UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations: UK Prospective Diabetes Study. Diabetologia 39:1505-1511, 1996
38. Lofman M, Yki-Jarvinen H, Parkkonen M, Lindstrom J, Koranyi L, Schalin-Jantti C, Groop L: Increased concentrations of glycogen synthase protein in skeletal muscle of patients with NIDDM. Am J Physiol 269:E27-E32, 1995
39. DePaoli-Roach AA, Suzuki Y, Lanner C, Zhang H, Yang J, Scrimgeour A, Lawrence JC: Glycogen metabolism in transgenic mice overexpressing or deficient in the muscle-specific glycogen/sarcoplasmic reticulum-associated phosphatase, PPIG (Abstract). Diabetes 48 (Suppl. 1):A25, 1990
40. Kida Y, Esposito-Del Puente A, Bogardus C, Mott DM: Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest 85:476-481, 1990
41. Nyomba BL, Brautigan DL, Schlender KK, Wang W, Bogardus C, Mott DM: Deficiency in phosphorylase phosphatase activity despite elevated protein phosphalasetype-1 catalytic subunit in skeletal muscle from insulin-resistant subjects. J Clin Invest 88:1540-1545, 1991
42. Sutherland C, Cohen P: The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Letters 338:37-42, 1994
43. Welsh GI, Patel JC, Proud CG: Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts. Anal Biochem 244:16-21, 1997
44. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P: The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303:21-26, 1994
45. Kim Y-B, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn B: In vivo activation of Akt/Protein kinase B (PKB) by insulin is normal in spite of decreased activation of phosphoinositide 3-kinase in skeletal muscle of humans with type 2 diabetes. J Clin Invest 104:733-741, 1990
46. Krook A, Roth RA, Jiang XI, Zierath JR, Wallberg-Henriksson H: Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47:1281-1286, 1998
47. Borthwick AC, Wells AM, Rochford JJ, Hurel SJ, Turnbull DM, Yeaman SJ: Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts. Biochem Biophys Res Commun 210:738-745, 1995
48. Hansen L, Arden KC, Rasmussen SB, Viars CS, Vestergaard H, Hansen T, Moller AM, Woodgett JR, Pedersen O: Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM. Diabetologia 40:940-946, 1997
49. Hoshi M, Sato M, Kondo S, Takashima A, Noguchi K, Takahashi M, Ishiguro K, Imahori K: Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinasp-3 alpha in cerebellum mitochondria. J Biochem 118:683-685, 1995
50. Yu JS, Chan WH, Yang SD: Selective interaction of protein kinase FA/glycogen synthase kinase-3alpha with membrane phospholipids. Biochem Biophys Res Commun 237:331-335, 1997
51. Nikoulina SK, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Henry RR: Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia. Diabetes 46:1017-1024, 1997
52. Eldar-Finkelman H, Krebs EG: Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Nat Acad Sci U S A 94:9660-9664, 1997
53. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271:665-668, 1996
54. Tanti JF, Gremeaux T, van Obberghen E, Le Marchand-Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057, 1994